MedTrace Logo

The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease

NCT02178839 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2014-07-01

No results posted yet for this study

Summary

The Objective of This Study is Evaluating the Effect of oral β- glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver echogenicity and Enzymes in Non Alcoholic Fatty Liver Patients Treating with Hypocaloric Diet and Vitamin E.

Conditions

  • Non Alcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT

β- glucan

8.5 g/d of Oat Supplement Containing 3g β- glucan

DIETARY_SUPPLEMENT

Maltodextrin

8.5 g/d Maltodextrin

Sponsors & Collaborators

  • Urmia University of Medical Sciences

    lead OTHER

Principal Investigators

  • Mohammad Alizadeh, PhD · Department of Nutrition, School of Medicine, Urmia University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-03-31

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178839 on ClinicalTrials.gov